Skip to Content
AHIP
webinars

The Importance of Administering RSV Monoclonal Antibody During Birth Hospitalization

Dates:
Jun 10, 2025
Time:
1:00 pm EDT
Register Now Registration takes place at a third-party website.

About This Webinar

CDC recommends for infants to be immunized against RSV within one week of birth, during the birth hospitalization or in the clinic setting. Administration in the hospital setting can help support uptake and prevent missed opportunities. This webinar will explore how payers can support access by engaging hospitals to increase inpatient immunization rates for infants born during the RSV season, decreasing risk of RSV infection in the first months of life and reducing total cost of care.

Start preparing for the 2025-2026 RSV season and join us!

Attendees Will Learn About

  • The clinical and public health importance of timely RSV mAb administration
  • Insights from the latest RSV Season
  • How the traditional newborn reimbursement framework disincentivizes administration during the birth hospitalization
  • Potential pathways for plans to support inpatient immunization in their network

Presenters

Richard H. Hughes IV, JD, MPH

Partner

Epstein Becker & Green, P.C.

Richard Hughes, IV, JD, MPH, is a partner at Epstein, Becker & Green and a professorial lecturer in law at The George Washington University Law School and a nationally recognized vaccine thought leader who has led many efforts to expand access to vaccines and preventive services and improve public health outcomes. Mr. Hughes was formerly Vice President of Public Policy at Moderna, guiding…

Learn more about Richard H. Hughes IV, JD, MPH